Equity - Incentive Equity Awards - Summary of Euity Awards Activity (Details) - USD ($)		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021
Stockholders Equity Note [Line Items]
Stock Options Issued		33,303	994,921
Gross Proceeds		$ 59,000	$ 2,616,050
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Common Shares Issued in settlement of RSUs and Performance Based RSUs Vested		1,458,806	1,202,590
Shares retained for settlement of employee tax obligations		344,318	454,973
Performance-Based RSUs
Stockholders Equity Note [Line Items]
Common Shares Issued in settlement of RSUs and Performance Based RSUs Vested	[1]		1,923,316
Shares retained for settlement of employee tax obligations			816,931

[1] Performance-based RSUs vested in connection with the achievement of certain regulatory and sales performance conditions associated with the REDUCE-IT clinical trial and subsequent revenue growth. These performance-based RSUs have fully vested as of August 2021.